Institution
Centre for Addiction and Mental Health
Recent research
- Health & MedicineOpen access
The practical impact of numerical variability on structural MRI measures of Parkinson’s disease
Abstract Numerical variability is rarely quantified in neuroimaging despite many measures relying on subtle morphometric differences across individuals. We instrumented FreeSurfer 7.3.1, a widely used neuroimaging pipeline, to simulate numerical differences across computational e...
- Society & EconomicsOpen access
Abstract Indigenous youth’s inherent strength and resilience play a vital role in their well-being and mental health. Protective factors, closely linked to resilience, spanning individual, family, and community levels reinforce positive mental health outcomes. The purpose of the...
- Society & EconomicsOpen access
BACKGROUND: Task-sharing with non-specialist providers offers a promising solution to the mental health workforce shortage in low-resource settings. Supervision is essential to ensure treatment quality, but is often constrained by limited specialist availability. AIMS: This study...
- BiologyOpen access
Xylazine Usage and Awareness Among People Who Use Drugs in Denver, Colorado
<b>Background</b>: Xylazine, also known as “tranq,” is an alpha-2 agonist with various effects including central nervous system depression, analgesia, and vasoconstriction. Since xylazine is a non-opioid, its effects are not reversible with ,bnaloxone, complicating overdose treat...
- Health & MedicineOpen access
In January 2023, British Columbia (BC) implemented a three-year decriminalization pilot to reduce harms of drug criminalization and address stigma toward people who use drugs. In May 2024, the policy was amended to “recriminalize” drug possession, a reform that excluded most publ...
- Health & Medicine
Objectives This study examined the point prevalence of patients with intellectual and developmental disabilities (IDDs) in Ontario forensic inpatient units and compared the demographic, clinical, and system-level profiles of long-stay forensic patients with and without IDD. Metho...
- Health & MedicineOpen access
There is growing evidence on the use of pitolisant for the treatment of residual excessive daytime sleepiness (EDS) in adults with obstructive sleep apnea (OSA) treated with continuous positive airway pressure (CPAP). We conducted a systematic review and meta-analysis of randomiz...